Search Results - "ARZUMANYAN, Alla"
-
1
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
Published in Nature reviews. Cancer (01-02-2013)“…Key Points Hepatitis B virus (HBV) and hepatitis C virus (HCV) are major aetiological agents of chronic liver disease and hepatocellular carcinoma (HCC). HCC…”
Get full text
Journal Article -
2
Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice
Published in Neoplasia (New York, N.Y.) (01-05-2021)“…Chronic infection with hepatitis B virus (HBV) is a major risk factor for the development of hepatocellular carcinoma (HCC). The HBV encoded oncoprotein, HBx,…”
Get full text
Journal Article -
3
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Published in Seminars in cancer biology (01-12-2015)“…Abstract Proliferation is an important part of cancer development and progression. This is manifest by altered expression and/or activity of cell cycle related…”
Get full text
Journal Article -
4
Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma
Published in Oncotarget (23-11-2021)“…Hepatitis B virus (HBV) is a human pathogen that has infected an estimated two billion people worldwide. Despite the availability of highly efficacious…”
Get full text
Journal Article -
5
Editorial: Microbiome metabolites in health and disease
Published in Frontiers in microbiology (12-09-2023)Get full text
Journal Article -
6
Preclinical Characterization of GLS4, an Inhibitor of Hepatitis B Virus Core Particle Assembly
Published in Antimicrobial Agents and Chemotherapy (01-11-2013)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
7
The roles of hepatitis B virus-encoded X protein in virus replication and the pathogenesis of chronic liver disease
Published in Expert opinion on therapeutic targets (01-03-2014)“…Hepatitis B virus (HBV) is a major cause of chronic liver disease (CLD) and hepatocellular carcinoma (HCC) worldwide. More than 350 million people are at risk…”
Get more information
Journal Article -
8
Does the Hepatitis B Antigen HBx Promote the Appearance of Liver Cancer Stem Cells?
Published in Cancer research (Chicago, Ill.) (15-05-2011)“…Hepatitis B virus (HBV) is a major etiologic agent of chronic liver disease and hepatocellular carcinoma (HCC). HBV-encoded X antigen, HBx, and pathways…”
Get full text
Journal Article -
9
Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis B
Published in Biomedicines (01-09-2022)“…Patients who are carriers of the hepatitis B virus (HBV) are at high risk of chronic liver disease (CLD) which proceeds from hepatitis, to fibrosis, cirrhosis…”
Get full text
Journal Article -
10
Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator
Published in Viruses (15-01-2021)“…While treatment options are available for hepatitis B virus (HBV), there is currently no cure. Anti-HBV nucleoside analogs and interferon-alpha 2b rarely clear…”
Get full text
Journal Article -
11
A spiroligomer α-helix mimic that binds HDM2, penetrates human cells and stabilizes HDM2 in cell culture
Published in PloS one (18-10-2012)“…We demonstrate functionalized spiroligomers that mimic the HDM2-bound conformation of the p53 activation domain. Spiroligomers are stereochemically defined,…”
Get full text
Journal Article -
12
Evaluation of Single and Combination Therapies with Tenofovir Disoproxil Fumarate and Emtricitabine In Vitro and in a Robust Mouse Model Supporting High Levels of Hepatitis B Virus Replication
Published in Antimicrobial Agents and Chemotherapy (01-12-2012)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
13
Short-chain fatty acids in cancer pathogenesis
Published in Cancer and metastasis reviews (01-09-2023)“…Cancer is a multi-step process that can be viewed as a cellular and immunological shift away from homeostasis in response to selected infectious agents,…”
Get full text
Journal Article -
14
Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer
Published in Oncogene (02-02-2012)“…Loss of E-cadherin is associated with acquisition of metastatic capacity. Numerous studies suggest that histone deacetylation and/or hypermethylation of CpG…”
Get full text
Journal Article -
15
Hedgehog Signaling Blockade Delays Hepatocarcinogenesis Induced by Hepatitis B Virus X Protein
Published in Cancer research (Chicago, Ill.) (15-11-2012)“…The hepatitis B virus (HBV) encoded X protein (HBx) contributes centrally to the pathogenesis of hepatocellular carcinoma (HCC). Aberrant activation of the…”
Get full text
Journal Article -
16
Effects of Ethanol on Mouse Embryonic Stem Cells
Published in Alcoholism, clinical and experimental research (01-12-2009)“…Background: Fetal alcohol syndrome (FAS) reflects a constellation of congenital abnormalities caused by excess maternal consumption of alcohol. It is likely…”
Get full text
Journal Article -
17
A prospective study of prognostic role of plasma circulating tumor DNA (ctDNA) in patients (pts) with early-stage malignancies
Published in Journal of clinical oncology (20-05-2020)“…Abstract only 3559 Background: Recently, conflicting evidence has emerged showing the association of ctDNA level and cancer progression. The aim of our study…”
Get full text
Journal Article -
18
Efficacy of nivolumab (Nivo) as 2+ line treatment and quality of life (QoL) in advanced refractory non-small cell lung cancer (NSCLC) patients: Interim results of observational prospective study
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
19
Observational study of the efficacy of nivolumab (Nivo) as 2+ line treatment and quality of life (QoL) in advanced refractory non-small cell lung cancer (NSCLC) patients: Interim analysis
Published in Journal of clinical oncology (20-05-2017)“…Abstract only e14593 Background: Therapy with immune checkpoint inhibitors (ICI) changed the paradigm of treatment in many solid tumors including NSCLC…”
Get full text
Journal Article -
20
Insulin receptor substrate (IRS)-1 regulates murine embryonic stem (mES) cells self-renewal
Published in Journal of cellular physiology (01-11-2007)“…Mouse embryonic stem (mES) cells are pluripotent cells that can be propagated in vitro with leukemia inhibitory factor (LIF) and serum. Intracellular signaling…”
Get full text
Journal Article